SEC 13F Intelligence

Synovus Financial Corp / ABBV

Synovus Financial Corp’s Abbvie Inc Position

Does Synovus Financial Corp own Abbvie Inc (ABBV)? Yes125.0K shares worth $29M (+0.33% of its 13F portfolio) as of Q3 2025, up from 122.6K shares the prior filed quarter.

Position Value
$29M
Q3 2025
Shares
125.0K
% of Portfolio
+0.33%
Quarters Held
28
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $16MQ4 ’18Q1 ’19: $10MQ2 ’19: $8MQ3 ’19: $8MQ4 ’19: $10MQ4 ’19Q1 ’20: $11MQ2 ’20: $13MQ3 ’20: $11MQ4 ’20: $13MQ4 ’20Q1 ’21: $13MQ2 ’21: $14MQ3 ’21: $13MQ4 ’21: $16MQ4 ’21Q1 ’22: $19MQ2 ’22: $18MQ3 ’22: $16MQ4 ’22: $20MQ4 ’22Q1 ’23: $19MQ2 ’23: $15MQ3 ’23: $18MQ4 ’23: $19MQ4 ’23Q1 ’24: $24MQ2 ’24: $22MQ3 ’24: $26MQ4 ’24: $22MQ4 ’24Q1 ’25: $25MQ2 ’25: $23MQ3 ’25: $29Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2025125.0K$29M+0.33%
Q2 2025122.6K$23M+0.28%
Q1 2025120.9K$25M+0.33%
Q4 2024122.1K$22M+0.28%
Q3 2024129.7K$26M+0.30%
Q2 2024131.0K$22M+0.30%
Q1 2024132.3K$24M+0.31%
Q4 2023123.6K$19M+0.27%
Q3 2023118.8K$18M+0.20%
Q2 2023112.7K$15M+0.17%
Q1 2023118.6K$19M+0.21%
Q4 2022120.8K$20M+0.22%
Q3 2022117.9K$16M+0.19%
Q2 2022116.6K$18M+0.21%
Q1 2022114.8K$19M+0.20%
Q4 2021119.6K$16M+0.16%
Q3 2021118.6K$13M+0.14%
Q2 2021121.2K$14M+0.13%
Q1 2021120.9K$13M+0.15%
Q4 2020125.1K$13M+0.15%
Q3 2020129.0K$11M+0.15%
Q2 2020129.6K$13M+0.18%
Q1 2020142.0K$11M+0.15%
Q4 2019108.0K$10M+0.13%
Q3 2019109.4K$8M+0.12%
Q2 2019107.7K$8M+0.12%
Q1 2019123.6K$10M+0.16%
Q4 2018172.8K$16M+0.29%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Synovus Financial Corp’s full portfolio or all institutional holders of ABBV.